Are Synthetic Cannabinoids (K2 / Spice) legal in France?

Legal status

Not applicable as a class status, because France reaches these compounds partly by name and partly by family clause. The dossier records the entry point as « JWH-018; AB-CHMINACA; familles et molécules classées », named molecules together with classified families. A molecule that is neither named in the arrêtés du 22 février 1990 nor inside one of the classified families is not controlled merely because it acts on the same receptors, so a product sold as a synthetic cannabinoid can fall inside or outside the lists depending on the exact compound. One status would be true of part of the class and false of the rest, which is why none is stated here.

Consequences if caught

Capital exposure: none. France abolished the death penalty and no French drug provision carries one. Beyond that no single ceiling can be stated, because the exposure is member specific: a narcotic constituent can engage Penal Code article 222-34 and life imprisonment for directing or organising a group formed for illicit narcotics activity, while a constituent reaching only the psychotropics order has to be assessed separately. JWH-018 and AB-CHMINACA are named in the dossier's own entry, and a molecule reached by a classified family clause and one that is not reached at all sit at opposite ends of the same label. Until the constituent is identified the honest statement is that the exposure is unsettled and could sit anywhere from no drug offence at all to the article 222-34 ceiling. Article L. 3421-1 of the Code de la santé publique addresses illicit use and stands apart from organised trafficking.

If prescribed or medical

France's country level rule is that a Schengen traveller certificate or a medicines carriage list is evidential and administrative rather than the criminal schedule. Attached to this label: there is no single schedule placement to attach, because the row's entry is recorded as « JWH-018; AB-CHMINACA; familles et molécules classées » and the placement follows the constituent. No prescribing route exists for the family label, and the dossier records none for any member. What was not established for this cell is which member is present, and without that the certificate has nothing to name.

Documentation

Carry the analytical identification of the molecule present, because a product label reading synthetic cannabinoid identifies nothing the order can be searched for. Provenance: the row's own entry is « JWH-018; AB-CHMINACA; familles et molécules classées », recorded against the consolidated narcotics and psychotropics orders of 22 February 1990 and read on Légifrance at https://www.legifrance.gouv.fr/loda/id/JORFTEXT000000533085 on 18 September 2026. The dossier classes this label among the five it marks not applicable for a single member independent answer, and that classification, not a failed search, is why this cell defers.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with France’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.